neuromuscular blockade
Conditions
Interventions
Group 1: No arms—pure observation:
Demographic data, pre-operative medication, pre-existing conditions at the time of induction of anesthesia, type and dosage of medications known at the time of induc
Sponsors
Universitätsklinikum Ulm
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults (> 18 years), surgical patients undergoing surgery under general anaesthesia requiring a single neuromuscular blockade with rocuronium and a planned operating time of > 60 minutes
Exclusion criteria
Exclusion criteria: • Emergency procedures • Patients who are unable to give consent or who are under guardianship • Pregnant women • Patients who have contraindications for rocuronium • Neuromuscular disorders that may affect neuromuscular monitoring
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is neuromuscular recovery time (time from administration of the muscle relaxant to a TOF ratio > 0.9). The time to neuromuscular recovery (TOF 0.9. The superiority of the model's prediction is assumed if the absolute difference between its prediction and the actual value is 33% less than that of the anesthesiologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Agreement between anesthesiologist, algorithm and reality | — |
Countries
Germany
Contacts
Public ContactFlora Scheffenbichler
Universitätsklinikum Ulm
Outcome results
None listed